KalVista Investigative Site

Evansville, Indiana 47715

1 studies enrolling now · 4 studies all time

What they study most

Hereditary Angioedema

Studies at this site

• Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II — Completed
• Treatment of Angioedema Attacks in Pediatric (Ages 2-11) Post-Trial and Naive Patients With HAE With Sebetralstat — Available (expanded access)
• PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial — Completed
• An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE) — Completed